Search Results - T M Ignatova

Telaprevir in treatment of chronic hepatitis C: safety issues by T. M. Ignatova

Get full text

STATE POLICY OF INNOVATION by A. M. Ignatova

Get full text

Making disperse nanosystems on the base of perfluoride organic compounds. by S. I. Vorobyev, E. V. Eskova, U. V. Luzganov, M. M. Ignatova

Get full text

Evaluation of the relationship between the minimum steady-state concentration of angiotensin II receptor blockers and polymorphic markers of CYP2C9 (Arg144Cys), CYP2C9 (IlE359Leu),... by E. V. Rebrova, E. V. Shikh, V. V. Smirnov, G. S. Anikin, L. M. Ignatova, M. M. Bogdanov

Get full text

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response by T. M. Ignatova, T. N. Lopatkina, V. P. Chulanov, Ye. V. Gaydasheva, S. N. Batskikh, G. V. Mikhaylovskaya, D. T. Abdurakhmanov, S. Yu. Karpov, Ye. N. Nikulkina, O. A. Chernova

Get full text

Immunogenic Activity of Secreted Protein-Based Compounds Staphylococcus aureus № 6 by I. M. Gruber, E. A. Astashkina, O. V. Lebedinskaya, N. B. Egorova, M. V. Kiselevsky, F. V. Donenko, N. E. Yastrebova, O. M. Ignatova, E. A. Kurbatova, L. S. Cherkasova

Get full text

Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience by N A Mukhin, P I Novikov, Sergey Valentinovich Moiseev, T M Ignatova, L V Kozlovskaya, E N Semenkova, V V Fomin, S V Gulyaev, T N Krasnova, L A Strizhakov, T N Yanushkevich, V V Panasyuk, N V Nikiforova, S V Roshchupkina, Yu D Sorokin, A D Meshkov, L V Dubrovskaya, E S Zhabina, S A Parfenova, E I Kuznetsova, I A Lopatina

Get full text